SCHEMBL6429398

SCHEMBL6429398

Cc1cccc(C)c1C1=C(C(F)(F)F)C(=O)N(Cc2ccccc2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NR1H2 P55055 3/20 0.41
NR1H3 Q13133 3/20 0.41
ELANE P08246 3/20 0.40
CTSG P08311 2/20 0.40
CASP3 P42574 1/20 0.40
F2 P00734 1/20 0.40
PLG P00747 1/20 0.40
CMA1 P23946 1/20 0.40
CTRC Q99895 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPK1 P28482 1/20 0.40
SIRT2 Q8IXJ6 1/20 0.39
GSK3A P49840 1/20 0.38
GSK3B P49841 1/20 0.38
MGLL Q99685 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6525603 0.81 NR1H2 (0.41) NPSR1L3MBTL1NR1H2NR1H3ELANE
SCHEMBL6426931 0.80 MAPT (0.48) NPSR1L3MBTL1NR1H2NR1H3ELANE
SCHEMBL6428548 0.77 NR1H2 (0.56) NPSR1L3MBTL1NR1H2NR1H3ELANE
SCHEMBL6426783 0.76 NR1H2 (0.47) NPSR1NR1H2NR1H3ELANECTSG
SCHEMBL6429546 0.75 OPRK1 (0.40) NPSR1NR1H2NR1H3ELANECTSG
SCHEMBL6429024 0.74 PTGS2 (0.46) NR1H2NR1H3
SCHEMBL2021877 0.74 NPSR1 (0.59) NPSR1L3MBTL1ELANECTSGCASP3
SCHEMBL6427487 0.73 DHPS (0.46) L3MBTL1NR1H2NR1H3SMN1; SMN2ALDH1A1
SCHEMBL6428246 0.72 GSK3B (0.39) NPSR1NR1H2NR1H3ELANECTSG
SCHEMBL6427166 0.72 CASP1 (0.47) NR1H2NR1H3CASP3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005024755-A2 MEDICAMENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS OR DIABETES DECIPHERA PHARMACEUTICALS, LLC. (US) 2005-03-17 WO disclosed